The Hikma Court correctly held that a generic manufacturer should not be liable for induced patent infringement if it carves patented uses out of its label. FDA can navigate Hikma’s aftermath without ...

Share on Pinterest Federal regulators have agreed to review a Swiss pharmaceutical company’s applications for two cheaper generic versions of Zepbound and Mounjaro. MK Photo/Alamy Stock Photo Federal ...

A generic semaglutide injection to promote weight loss is now approved in Canada, Health Canada says. The regulator said the product submission, called Svemia, was filed by Canadian-based Apotex and ...

ZURICH, June 29 (Reuters) - The U.S. Food and Drug Administration has agreed to review Swiss generics drugmaker Sandoz's (SDZ.S), opens new tab two generic tirzepatide GLP-1s that, ‌if approved, would ...

Most organizations treat AI adoption as a technology challenge—a software rollout to be managed by IT and celebrated by the C-suite. Some even see it as a fast track to headcount reduction. Julia Shin ...

FDA cleared generic rifapentine for active pulmonary TB (≥12 years) with susceptible isolates, requiring combination therapy with other active antitubercular agents. Authorization also covers LTBI (≥2 ...

Macitentan tablets are used to treat pulmonary arterial hypertension. The FDA approval of Selarsdi 130 mg/26 ml in a single-dose vial for intravenous infusion expands the label to include treatment of ...

Each day, millions of people pick up a prescription drug from their local pharmacy or mailbox. Most are affordable, with co-pays on average less than $7 for 90% of drugs. But for a growing number of ...

Hims & Hers Health (HIMS) on Thursday announced the launch of generic versions of Novo Nordisk’s (NVO) blockbuster GLP-1 therapy semaglutide through its telehealth platform in Canada. The ...

The Trump administration has expanded TrumpRx to include more than 600 generic medications — a significant scale-up from the platform’s original focus on branded drugs under most-favored-nation ...

India got it earlier this year, and Canada approved it last month. But when is the United States going to get a generic version of Ozempic? Not this decade, experts say. Thanks largely to loopholes in ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The day has ...